Clinical Trial Update: German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa

View source ↗

Summary

This clinical trial update describes an observational multicenter study in Germany evaluating patients with Fabry disease who are receiving enzyme replacement t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Pegunigalsidase alfa (pegunigalsidase alfa)

Snippet

Sponsor: Universität Münster | Conditions: Fabry Disease | Status: RECRUITING